DEBORAH TUNNY: Open Payments
NPI 1235401381 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$585 in 24 payments from 15 companies in 2025. Trend: 2023 $402 · 2024 $471 · 2025 $585
Food & beverage: $542Education: $43
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 2 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $63 |
| Insulet Corporation | 3 | $55 |
| Medtronic, Inc. | 1 | $53 |
| Mannkind Corporation | 1 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $34 |
| Novo Nordisk Inc | 2 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Averitas Pharma Inc. | 1 | $23 |
Products named: iLet Bionic Pancreas, Kerendia, Omnipod, MINIMED 780G, AFREZZA, GVOKE HYPOPEN, CRENESSITY, QUTENZA.
Industry payments across IN — which companies pay providers there.
